新泽西州拉威 - 全球医疗保健领导者默沙东集团（NYSE: MRK）已完成收购Curon Biopharmaceutical的新型双特异性抗体CN201，从而增强其管线中用于治疗B细胞恶性肿瘤和自身免疫性疾病的潜在药物。这笔交易涉及约7.5亿美元的预付款和相关费用，将反映在默沙东集团第三季度的非GAAP业绩中。

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

智通财经APP获悉，9月26日，美国FDA顾问小组将重点讨论施贵宝(BMY.US)的Opdivo (nivolumab)和默沙东(MRK.US)的Keytruda ...

We recently compiled a list of the 10 Undervalued Wide Moat Stocks to Buy According to Analysts. In this article, we are ...

Check the time stamp on this data. Updated AI-Generated Signals for Merck & Company Inc. (MRK) available here: MRK.

On Friday, Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $113.69 which represents a slight increase of $0.60 or 0.53% from the prior close of $113.09. The stock opened at $113.17 ...

2024年9月30日，制药公司默沙东（MRK）成交额为12.43亿美元，在当日美股中排第43名，成交额较昨日减少8.20%，当日成交量为1095.00万。 默沙东（MRK）于2024年9月30日跌0.12%，报113.55美元，该股过去5个交易日跌1.80%，整个9月跌4.14%，年初至今涨4.16%，过去52周涨10.30%。

We recently compiled a list of the 7 Undervalued Blue Chip Stocks To Buy Right Now. In this article, we are going to take a ...

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Earnings Yield Investor model based on the published strategy ...

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Earnings Yield Investor model based on the published strategy ...

新泽西州拉威 - 默沙东集团(NYSE:MRK)旗下的默沙东动物保健部门宣布推出一款新型疫苗NOBIVAC NXT FeLV，用于保护猫咪免受猫白血病病毒(FeLV)的侵害。这款采用RNA颗粒技术的疫苗将于今年秋季在美国各地的兽医诊所和医院上市。 NOBIVAC NXT FeLV是默沙东首款利用RNA颗粒平台技术的FeLV疫苗，这一技术与该公司最近推出的狂犬病和犬流感疫苗所使用的技术类似。默沙东动 ...